Report of Foreign Issuer (6-k)
January 05 2018 - 7:32AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO SECTION 13a-16 OR
15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934
January 5, 2018
001-36686
(Commission file number)
Forward Pharma A/S
(Translation of registrant’s name into English)
Østergade 24A, 1st Floor
1100 Copenhagen K, Denmark
(Address of principal executive office)
________________________________________
Indicate by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F.
Form 20-F [ X ] Form 40-F [ ]
Indicate by check mark if the registrant is submitting the Form 6-K
in paper as permitted by Regulation S-T Rule 101(b)(1): Yes [ ] No [ X ]
Indicate by check mark if the registrant is submitting the Form 6-K
in paper as permitted by Regulation S-T Rule 101(b)(7): Yes [ ] No [ X ]
Indicate by check mark whether by furnishing the information contained
in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the
Securities Exchange Act of 1934. Yes [ ] No [ X ]
If “Yes” is marked, indicate below the file number assigned to the registrant
in connection with Rule 12g3-2(b): N/A
Item 1. Company Presentation
On January 5, 2018, Forward Pharma A/S (the “Company”)
made available an updated investor presentation on its website. A copy of the investor presentation is attached hereto as Exhibit
99.1.
The fact that this presentation is being made available and filed
herewith should not be deemed an admission as to the materiality of any information contained in the materials. The information
contained in the presentation is being provided as of January 5, 2018 and the Company does not undertake any obligation to update
the presentation in the future or to update forward-looking statements to reflect subsequent actual results.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly
caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
|
|
|
|
|
|
Date: January 5, 2018
|
|
|
|
Forward Pharma A/S
|
|
|
|
|
|
|
|
|
By:
|
|
/s/ Claus Bo Svendsen
|
|
|
|
|
|
|
Name: Claus Bo Svendsen
|
|
|
|
|
|
|
Title: Chief Executive Officer
|
EXHIBIT INDEX
Forward Pharma AS (NASDAQ:FWP)
Historical Stock Chart
From Sep 2024 to Oct 2024
Forward Pharma AS (NASDAQ:FWP)
Historical Stock Chart
From Oct 2023 to Oct 2024